The changing clinical spectrum of primary aldosteronism

Emmanuel L. Bravo, Robert C. Tarazi, Harriet P. Dustan, Fetnat M. Fouad, Stephen C. Textor, Ray W. Gifford, Donald G. Vidt

Research output: Contribution to journalArticle

220 Scopus citations

Abstract

In a prospective study of 80 patients with primary aldosteronism (70 with adenoma and 10 with hyperplasia), "refractory" hypertension, hyperkinetic circulation, and hypovolemia were frequent occurrences. We found that measurements of serum potassium concentration and plasma renin activity were inadequate screening tests because of high rates of false-positive and false-negative results. The demonstration of excessive aldosterone production after three days of salt loading provided the best sensitivity (96 percent) and specificity (93 percent) in identifying patients with primary aldosteronism. Severe, persistent hypokalemia, increased plasma 18-hydroxycorticosterone values, and an anomalous postural decrease in the plasma aldosterone concentration, when present, provided the best indicators of the presence of an adenoma. Of three localizing procedures (selective adrenal venography, adrenal computed tomographic scan, and adrenal venous sampling for plasma aldosterone concentration) the measurement of adrenal venous plasma aldosterone concentration yielded 100 percent accuracy. These results indicate a wider clinical spectrum in primary aldosteronism than previously described. They also show that nonsuppressible aldosterone production is its most important diagnostic hallmark and the single best diagnostic screening procedure, and that adrenal venous sampling for plasma aldosterone concentration remains the most precise technique for identification and localization of tumors.

Original languageEnglish (US)
Pages (from-to)641-651
Number of pages11
JournalThe American Journal of Medicine
Volume74
Issue number4
DOIs
StatePublished - Apr 1983

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The changing clinical spectrum of primary aldosteronism'. Together they form a unique fingerprint.

  • Cite this

    Bravo, E. L., Tarazi, R. C., Dustan, H. P., Fouad, F. M., Textor, S. C., Gifford, R. W., & Vidt, D. G. (1983). The changing clinical spectrum of primary aldosteronism. The American Journal of Medicine, 74(4), 641-651. https://doi.org/10.1016/0002-9343(83)91022-7